Sign Up Today and Learn More About Cullgen Stock
Invest in or calculate the value of your shares in Cullgen or other pre-IPO companies through EquityZen's platform.
Cullgen Stock (CULL)
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.
About Cullgen Stock
Founded
2018
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Cullgen Press Mentions
Stay in the know about the latest news on Cullgen
Gyre Therapeutics Announces China’s NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment
biospace • Mar 17, 2026
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
biospace • Mar 12, 2026
一家ä¸ĺ›˝Biotech，卖了
phirda • Mar 06, 2026
Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline
sdbn • Mar 03, 2026
Gyre, Cullgen Merge in $300M All-Stock Deal
law360 • Mar 03, 2026
Cullgen Management
Leadership team at Cullgen
Chairman and President
Ying Luo
Co-Founder
Jian Jin
Join now and verify your accreditation status to gain access to:
- Cullgen Current Valuation
- Cullgen Stock Price
- Cullgen Management
- Available deals in Cullgen and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Cullgen Cap Table and Funding History by Share Class and Liquidity Preferences
- Cullgen Revenue and Financials
- Cullgen Highlights
- Cullgen Business Model
- Cullgen Risk Factors
- Cullgen Research Report from SACRA Research
Trading Cullgen Stock
How to invest in Cullgen stock?
Accredited investors can buy pre-IPO stock in companies like Cullgen through EquityZen funds. These investments are made available by existing Cullgen shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Cullgen stock?
Shareholders can sell their Cullgen stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
